A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
Primary Purpose
NSTEMI
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Shared Decision Aid
Sponsored by
About this trial
This is an interventional treatment trial for NSTEMI focused on measuring Shared decision making, Left heart catheterization, Non-ST elevation myocardial infarction, Decisional conflict, Decision aid
Eligibility Criteria
Inclusion Criteria:
- Must be admitted to the hospital, and there must be clinical suspicion for type I NSTEMI
- Must be eligible for non-urgent revascularization
- Must have capacity to consent for the study based on the judgment of the study investigators
- Must speak English
Exclusion Criteria:
- Does not meet all of the inclusion criteria listed above
- Has significant vision or hearing impairment that prohibits use of the decision aid
- Unable to read
- Has a clinical diagnosis of dementia and/or severe cognitive impairment documented in the electronic medical record
Sites / Locations
- NYU Langone Health
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Standard of care
Shared decision aid
Arm Description
Patients in the control arm of the study will undergo standard of care treatment, discussing catheterization with their treating physicians.
Patients in the interventional arm of the study will discuss catheterization with their treating physicians, in addition to having access to the shared decision aid tool and a shared decision conversation with a co-investigator clinician.
Outcomes
Primary Outcome Measures
Percent change in mean decisional conflict score between the control and interventional group
A reduction in decisional conflict score will be measured with the DCS tool to reflect an increase in the quality of the decision.
Secondary Outcome Measures
Descriptive Statistics in the use of the Patient Decision Aid
Descriptive differences in the participants who use the patient decision aid and those who are in the control group will be measured with study surveys
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04270630
Brief Title
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
Official Title
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients (Age ≥75) Considering Left Heart Catheterization as Treatment for Non-St Elevation Myocardial Infarction
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
December 1, 2022 (Actual)
Study Completion Date
December 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will be a single-center, prospective, un-blinded, randomized controlled trial evaluating a decision aid tool for older patients considering left heart catheterization (LHC) as treatment for non-ST elevation myocardial infarction (NSTEMI). The study population is 50 total inpatients (25 per study arm) with NSTEMI eligible for elective LHC. The first arm is the control group that will receive standard of care, while the second arm will have access to the decision aid and shared-decision making conversation with one of the co-investigators. Baseline characteristics and surveys/questionnaire data will be collected after study intervention (as applicable), and prior to final decision regarding LHC. Statistical analyses will be conducted on the primary endpoint, decisional conflict score, as well as on various secondary endpoints.
Detailed Description
A single-center, prospective, un-blinded, randomized controlled trial. Primary objective: To pilot a coronary revascularization decision aid in older adults with NSTEMI who are candidates for elective LHC in order to determine its effectiveness in lowering decisional conflict by the decisional conflict scale (DCS).
Secondary objectives: To determine decision aid feasibility by measuring time of administration and percentage of patients agreeing to use. Also, to assess efficacy of the decision aid in decreasing patient feelings of anxiety and depression (by the Hospital Anxiety and Depression Scale), increasing decision self-efficacy (by the Ottawa Decision Self-Efficacy Scale), and increasing medical knowledge.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
NSTEMI
Keywords
Shared decision making, Left heart catheterization, Non-ST elevation myocardial infarction, Decisional conflict, Decision aid
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Standard of care
Arm Type
No Intervention
Arm Description
Patients in the control arm of the study will undergo standard of care treatment, discussing catheterization with their treating physicians.
Arm Title
Shared decision aid
Arm Type
Experimental
Arm Description
Patients in the interventional arm of the study will discuss catheterization with their treating physicians, in addition to having access to the shared decision aid tool and a shared decision conversation with a co-investigator clinician.
Intervention Type
Behavioral
Intervention Name(s)
Shared Decision Aid
Intervention Description
The decision aid was developed by this study group based on the International Patient Decision Aid Standards Collaboration's minimum standards for quality, and the Ottawa Framework (a process by which patients' and clinicians' decision determinants are assessed, a decision aid is developed that is tailored to these needs, and the quality of the decision-making process with the aid is evaluated). The aid then underwent an iterative feedback process with a patient advisory panel. Adjustments to format, length, and readability were made. A final feedback session occurred with three patients over the age of 70, after which point the paper decision aid was digitalized. The intervention will be delivered in-person by one of the co-investigators of the study. The intervention will occur once, prior to the patient making a final decision regarding undergoing left heart catheterization as treatment for NSTEMI. The approximate duration of the intervention is 30 minutes.
Primary Outcome Measure Information:
Title
Percent change in mean decisional conflict score between the control and interventional group
Description
A reduction in decisional conflict score will be measured with the DCS tool to reflect an increase in the quality of the decision.
Time Frame
Visit 1 (Day 0)
Secondary Outcome Measure Information:
Title
Descriptive Statistics in the use of the Patient Decision Aid
Description
Descriptive differences in the participants who use the patient decision aid and those who are in the control group will be measured with study surveys
Time Frame
Visit 1 (Day 0)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Must be admitted to the hospital, and there must be clinical suspicion for type I NSTEMI
Must be eligible for non-urgent revascularization
Must have capacity to consent for the study based on the judgment of the study investigators
Must speak English
Exclusion Criteria:
Does not meet all of the inclusion criteria listed above
Has significant vision or hearing impairment that prohibits use of the decision aid
Unable to read
Has a clinical diagnosis of dementia and/or severe cognitive impairment documented in the electronic medical record
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Dodson, MD
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following article publication.
IPD Sharing Access Criteria
The investigator who proposed to use the data. Upon reasonable request. Requests should be directed to rachel.sibley@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Learn more about this trial
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
We'll reach out to this number within 24 hrs